Cabazirix 60 mg Injection 6 ml belongs to a group of medicines known as microtubule inhibitors. It is used to treat advanced prostate cancer or metastatic prostate cancer that has already been treated with other medications. Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can attack and destroy surrounding healthy tissue, including organs. Prostate cancer is a type of cancer that only occurs in men and affects the prostate gland, a tiny gland under the bladder that produces semen.

Cabazirix 60 mg Injection 6 ml contains Cabazitaxel, a microtubule receptor blocker (inhibitor). Cabazitaxel shrinks tumours by attacking rapidly dividing cells, including cancer cells, so they can no longer grow and divide.

Cabazirix 60 mg Injection 6 ml should be administered to patients only in a hospital setting under the supervision of a physician qualified by training and experience to administer cancer chemotherapeutic agents. Sometimes, you may experience common side effects, such as being sick (vomiting), neutropenia (lower-than-normal levels of neutrophils), low blood cell count, diarrhoea, vomiting, constipation, asthenia (abnormal weakness), pyrexia (fever), dyspnea (shortness of breath), altered taste, cough, pain in the joint, and alopecia (hair loss). Most of these side effects may gradually resolve over time. However, if the side effects persist or worsen, consult your doctor.

Cabazitaxel is only for use in men. Men using this Cabazirix 60 mg Injection 6 ml must use effective birth control whenever they have sex during your treatment and four months after their final dose. Women should not take this medication, especially if they are or may become pregnant or are breast-feeding. Cabazitaxel injection may result in a substantial or life-threatening decrease in the number of white blood cells (a kind of blood cell needed to fight infection) in your blood. This increases your chances of developing a serious infection. Inform your doctor if you are 65 or older if you have or have ever had a low number of white blood cells associated with a fever if you have had radiation therapy, or if you are unable to eat a nutritious diet. Before and during treatment, your doctor will conduct laboratory tests to determine the quantity of white blood cells in your blood. If you have a low white blood cell count, your doctor may reduce your dose or stop or postpone your therapy. If your white blood cell count drops, your doctor may prescribe a prescription to help prevent life-threatening problems.

Cabazirix 60 mg Injection 6 ml contains Cabazitaxel, which belongs to a group of medicines known as microtubule inhibitors. Cabazitaxel shrinks tumours by attacking rapidly dividing cells, including cancer cells, so they can no longer grow and divide.

Before taking the Cabazirix 60 mg Injection 6 ml, let your doctor know about all your allergic or hypersensitivity reactions to medicines or food. White blood cells protect the body from infection. This medication may cause a decrease in the amount of white blood cells in your blood (neutropenia). You are more prone to catching an infection if your white blood cell count is low. When the quantity of white blood cells is too low, an infection can be deadly. It is critical to treat any infection as quickly as possible. Make an immediate call to the hospital. Use a condom or effective birth control method if you are having sex with pregnant women or women who can become pregnant. Cabazitaxel injection can produce severe or life-threatening allergic reactions, especially during the first two infusions. Your doctor will give you drugs to prevent an allergic response at least 30 minutes before the Cabazitaxel injection. You should receive your infusion in a medical institution where you may be treated swiftly if you develop an allergic reaction.